Corium Presents Additional Positive Clinical Results at Alzheimer’s Association International Converence^® 2018
Pharmacodynamic Results Further Support Therapeutic Equivalence of Corplex™ Donepezil to Aricept® MENLO PARK, Calif. , July 25, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and…

Corium Announces Issuance of Additional U.S. Patent Covering Corplex^TM Donepezil Transdermal System for Alzheimer’s Disease
Second Orange Book Listable Patent Provides Expanded Coverage to 2037 MENLO PARK, Calif. , July 11, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal…